Insights into cancer metastasis from a clinicopathologic perspective: Epithelial-Mesenchymal Transition is not a necessary step

International Journal of Cancer

Volumn 132, Issue 7, 2013, Pages 1487-1495

  Chui, Michael Herman ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

cancer stem cells; dedifferentiation; epithelial mesenchymal transition; immortalized epithelial progenitor phenotype; metastasis; pathology

Indexed keywords

BETA CATENIN; CALVASCULIN; CYTOKERATIN 20; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KERATIN; MUCIN 2; NERVE CELL ADHESION MOLECULE; SMAD PROTEIN; SMOOTH MUSCLE ACTIN; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN; VIMENTIN; WNT PROTEIN;

BASAL LIKE BREAST CANCER; CANCER CELL; CANCER GROWTH; CANCER INVASION; CANCER SURGERY; CARCINOSARCOMA; CELL DEDIFFERENTIATION; CELL IMMORTALIZATION; CELL MIGRATION; CELL RENEWAL; CELL STRUCTURE; CHROMOSOME ABERRATION; COLORECTAL CANCER; DISTANT METASTASIS; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE MUTATION; GERM CELL TUMOR; HUMAN; KIDNEY CARCINOMA; LIVER CELL CARCINOMA; METASTASIS; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; REVIEW; STEM CELL; THYROID FOLLICULAR CARCINOMA; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION;

ANIMALS; CELL DIFFERENTIATION; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; NEOPLASM METASTASIS; NEOPLASMS;

EID: 84873094470     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.27745     Document Type: Review

References (101)

1. Tarin D, Thompson EW, Newgreen DF,. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 2005; 65: 5996-6000.
2. Kalluri R, Weinberg RA,. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119: 1420-8.
3. Nieto MA,. The ins and outs of the epithelial to mesenchymal transition in health and disease. Annu Rev Cell Dev Biol 2011; 27: 347-76.
4. Khoury H, Dankort DL, Sadekova S, et al. Distinct tyrosine autophosphorylation sites mediate induction of epithelial mesenchymal like transition by an activated ErbB-2/Neu receptor. Oncogene 2001; 20: 788-99.
5. Oft M, Peli J, Rudaz C, et al. TGF-beta1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev 1996; 10: 2462-77.
6. Howard S, Deroo T, Fujita Y, et al. A positive role of cadherin in Wnt/beta-catenin signalling during epithelial-mesenchymal transition. PLoS One 2011; 6: e23899.
7. Huber MA, Azoitei N, Baumann B, et al. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest 2004; 114: 569-81.
8. Yang J, Mani SA, Donaher JL, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004; 117: 927-39.
9. Mani SA, Guo W, Liao MJ, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-15.
10. Tarin D,. Inappropriate gene expression in human cancer and its far-reaching biological and clinical significance. Cancer Metastasis Rev 2011; 31 (1-2): 21-39.
11. Mills SE, Carter D, Greenson JK, Reuter VE, Stoler MH. Sternberg's Diagnostic Surgical Pathology, 5th edn. Lippincott Williams & Wilkins, 2009.
12. Yeung T, Georges PC, Flanagan LA, et al. Effects of substrate stiffness on cell morphology, cytoskeletal structure, and adhesion. Cell Motil Cytoskeleton 2005; 60: 24-34.
13. Li B, Zheng YW, Sano Y, et al. Evidence for mesenchymal-epithelial transition associated with mouse hepatic stem cell differentiation. PLoS One 2011; 6: e17092.
14. Kriz W, Kaissling B, Le Hir M,. Epithelial-mesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? J Clin Invest 2011; 121: 468-74.
15. Shipitsin M, Campbell LL, Argani P, et al. Molecular definition of breast tumor heterogeneity. Cancer Cell 2007; 11: 259-73.
16. Korita PV, Wakai T, Ajioka Y, et al. Aberrant expression of vimentin correlates with dedifferentiation and poor prognosis in patients with intrahepatic cholangiocarcinoma. Anticancer Res 2010; 30: 2279-85.
17. Blanco MJ, Moreno-Bueno G, Sarrio D, et al. Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene 2002; 21: 3241-6.
18. Bignold LP,. Pathogenetic mechanisms of nuclear pleomorphism of tumour cells based on the mutator phenotype theory of carcinogenesis. Histol Histopathol 2003; 18: 657-64.
19. Zhivotovsky B, Kroemer G,. Apoptosis and genomic instability. Nat Rev Mol Cell Biol 2004; 5: 752-62.
20. Cahill DP, Lengauer C, Yu J, et al. Mutations of mitotic checkpoint genes in human cancers. Nature 1998; 392: 300-3.
21. Overholtzer M, Rao PH, Favis R, et al. The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability. Proc Natl Acad Sci USA 2003; 100: 11547-52.
22. Lengauer C, Kinzler KW, Vogelstein B,. Genetic instabilities in human cancers. Nature 1998; 396: 643-9.
23. Harvey M, Sands AT, Weiss RS, et al. In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene 1993; 8: 2457-67.
24. Bozic I, Antal T, Ohtsuki H, et al. Accumulation of driver and passenger mutations during tumor progression. Proc Natl Acad Sci USA 2010; 107: 18545-50.
25. Chin L, Hahn WC, Getz G, et al. Making sense of cancer genomic data. Genes Dev 2011; 25: 534-55.
26. Montel V, Suzuki M, Galloy C, et al. Expression of melanocyte-related genes in human breast cancer and its implications. Differentiation 2009; 78: 283-91.
27. Zhang Q, Fan H, Shen J, et al. Human breast cancer cell lines co-express neuronal, epithelial, and melanocytic differentiation markers in vitro and in vivo. PLoS One 2010; 5: e9712.
28. Ruiter DJ, van Krieken JH, van Muijen GN, et al. Tumour metastasis: is tissue an issue? Lancet Oncol 2001; 2: 109-12.
29. Fidler IJ,. Metastasis: guantitative analysis of distribution and fate of tumor embolilabeled with 125 I-5-iodo-2′-deoxyuridine. J Natl Cancer Inst 1970; 45: 773-82.
30. Friedl P, Gilmour D,. Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol 2009; 10: 445-57.
31. Thompson SC,. The colony forming efficiency of single cells and cell aggregates from a spontaneous mouse mammary tumour using the lung colony assay. Br J Cancer 1974; 30: 332-36.
32. Liotta LA, Kleinerman J, Saidel GM,. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res 1974; 34: 997-1004.
33. Mete O, Asa SL,. Pathological definition and clinical significance of vascular invasion in thyroid carcinomas of follicular epithelial derivation. Mod Pathol 2011; 24: 1545-52.
34. Sugino T, Kusakabe T, Hoshi N, et al. An invasion-independent pathway of blood-borne metastasis: a new murine mammary tumor model. Am J Pathol 2002; 160: 1973-80.
35. Sugino T, Yamaguchi T, Ogura G, et al. Morphological evidence for an invasion-independent metastasis pathway exists in multiple human cancers. BMC Med 2004; 2: 9.
36. Kusters B, Kats G, Roodink I, et al. Micronodular transformation as a novel mechanism of VEGF-A-induced metastasis. Oncogene 2007; 26: 5808-15.
37. Sarrio D, Rodriguez-Pinilla SM, Hardisson D, et al. Epithelial- mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 2008; 68: 989-97.
38. Bharat A, Gao F, Margenthaler JA,. Tumor characteristics and patient outcomes are similar between invasive lobular and mixed invasive ductal/lobular breast cancers but differ from pure invasive ductal breast cancers. Am J Surg 2009; 198: 516-9.
39. Li CI, Moe RE, Daling JR,. Risk of mortality by histologic type of breast cancer among women aged 50 to 79 years. Arch Intern Med 2003; 163: 2149-53.
40. Kats-Ugurlu G, Roodink I, de Weijert M, et al. Circulating tumour tissue fragments in patients with pulmonary metastasis of clear cell renal cell carcinoma. J Pathol 2009; 219: 287-93.
41. Hou JM, Krebs MG, Lancashire L, et al. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. J Clin Oncol 2012; 30: 525-32.
42. Stott SL, Hsu CH, Tsukrov DI, et al. Isolation of circulating tumor cells using a microvortex-generating herringbone-chip. Proc Natl Acad Sci USA 2010; 107: 18392-7.
43. Vlems FA, Ruers TJ, Punt CJ, et al. Relevance of disseminated tumour cells in blood and bone marrow of patients with solid epithelial tumours in perspective. Eur J Surg Oncol 2003; 29: 289-302.
44. Mook OR, Van Marle J, Vreeling-Sindelarova H, et al. Visualization of early events in tumor formation of eGFP-transfected rat colon cancer cells in liver. Hepatology 2003; 38: 295-304.
45. Glinsky VV, Glinsky GV, Glinskii OV, et al. Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium. Cancer Res 2003; 63: 3805-11.
46. Al-Mehdi AB, Tozawa K, Fisher AB, et al. Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat Med 2000; 6: 100-2.
47. Tarin D, Price JE, Kettlewell MG, et al. Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts. Cancer Res 1984; 44: 3584-92.
48. Fidler IJ, Kripke ML,. Metastasis results from preexisting variant cells within a malignant tumor. Science 1977; 197: 893-5.
49. Shackleton M, Quintana E, Fearon ER, et al. Heterogeneity in cancer: cancer stem cells versus clonal evolution. Cell 2009; 138: 822-9.
50. Nowell PC,. The clonal evolution of tumor cell populations. Science 1976; 194: 23-8.
51. Sidransky D, Mikkelsen T, Schwechheimer K, et al. Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 1992; 355: 846-7.
52. Yachida S, Jones S, Bozic I, et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010; 467: 1114-7.
53. Alcock HE, Stephenson TJ, Royds JA, et al. Analysis of colorectal tumor progression by microdissection and comparative genomic hybridization. Genes Chromosomes Cancer 2003; 37: 369-80.
54. Glockner S, Buurman H, Kleeberger W, et al. Marked intratumoral heterogeneity of c-myc and cyclinD1 but not of c-erbB2 amplification in breast cancer. Lab Invest 2002; 82: 1419-26.
55. Ding L, Ellis MJ, Li S, et al. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 2010; 464: 999-1005.
56. Singhi AD, Cimino-Mathews A, Jenkins RB, et al. MYC gene amplification is often acquired in lethal distant breast cancer metastases of unamplified primary tumors. Mod Pathol 2012; 25: 378-87.
57. O'Brien CA, Kreso A, Dick JE,. Cancer stem cells in solid tumors: an overview. Semin Radiat Oncol 2009; 19: 71-7.
58. Cho RW, Clarke MF,. Recent advances in cancer stem cells. Curr Opin Genet Dev 2008; 18: 48-53.
59. Barabe F, Kennedy JA, Hope KJ, et al. Modeling the initiation and progression of human acute leukemia in mice. Science 2007; 316: 600-4.
60. Vermeulen L, De Sousa EMF, van der Heijden M, et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 2010; 12: 468-76.
61. Varlakhanova NV, Cotterman RF, deVries WN, et al. myc maintains embryonic stem cell pluripotency and self-renewal. Differentiation 2010; 80: 9-19.
62. Perry JM, He XC, Sugimura R, et al. Cooperation between both Wnt/{beta}-catenin and PTEN/PI3K/Akt signaling promotes primitive hematopoietic stem cell self-renewal and expansion. Genes Dev 2011; 25: 1928-42.
63. Antoun GR, Re GG, Terry NH, et al. Molecular genetic evidence for a differentiation-proliferation coupling during DMSO-induced myeloid maturation of HL-60 cells: role of the transcription elongation block in the c-myc gene. Leuk Res 1991; 15: 1029-36.
64. Singh AM, Reynolds D, Cliff T, et al. Signaling network crosstalk in human pluripotent cells: a Smad2/3-regulated switch that controls the balance between self-renewal and differentiation. Cell Stem Cell 2012; 10: 312-26.
65. Matushansky I, Radparvar F, Skoultchi AI,. CDK6 blocks differentiation: coupling cell proliferation to the block to differentiation in leukemic cells. Oncogene 2003; 22: 4143-9.
66. Smith KN, Singh AM, Dalton S,. Myc represses primitive endoderm differentiation in pluripotent stem cells. Cell Stem Cell 2010; 7: 343-54.
67. Korkola JE, Houldsworth J, Chadalavada RS, et al. Down-regulation of stem cell genes, including those in a 200-kb gene cluster at 12p13.31, is associated with in vivo differentiation of human male germ cell tumors. Cancer Res 2006; 66: 820-7.
68. Ben-Porath I, Thomson MW, Carey VJ, et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet 2008; 40: 499-507.
69. Quintana E, Shackleton M, Sabel MS, et al. Efficient tumour formation by single human melanoma cells. Nature 2008; 456: 593-8.
70. Pece S, Tosoni D, Confalonieri S, et al. Biological and molecular heterogeneity of breast cancers correlates with their cancer stem cell content. Cell 2010; 140: 62-73.
71. Taylor-Papadimitriou J, Stampfer M, Bartek J, et al. Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: relation to in vivo phenotypes and influence of medium. J Cell Sci 1989; 94 (Pt 3): 403-13.
72. Tesei A, Zoli W, Arienti C, et al. Isolation of stem/progenitor cells from normal lung tissue of adult humans. Cell Prolif 2009; 42: 298-308.
73. Horvay K, Casagranda F, Gany A, et al. Wnt signaling regulates Snai1 expression and cellular localization in the mouse intestinal epithelial stem cell niche. Stem Cells Dev 2011; 20: 737-45.
74. Rukstalis JM, Habener JF,. Snail2, a mediator of epithelial-mesenchymal transitions, expressed in progenitor cells of the developing endocrine pancreas. Gene Expr Patterns 2007; 7: 471-9.
75. Dhasarathy A, Phadke D, Mav D, et al. The transcription factors snail and slug activate the transforming growth factor-Beta signaling pathway in breast cancer. PLoS One 2011; 6: e26514.
76. Stemmer V, de Craene B, Berx G, et al. Snail promotes Wnt target gene expression and interacts with beta-catenin. Oncogene 2008; 27: 5075-80.
77. Watabe T, Miyazono K,. Roles of TGF-beta family signaling in stem cell renewal and differentiation. Cell Res 2009; 19: 103-15.
78. Amit M, Shariki C, Margulets V, et al. Feeder layer- and serum-free culture of human embryonic stem cells. Biol Reprod 2004; 70: 837-45.
79. Batard P, Monier MN, Fortunel N, et al. TGF-(beta)1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation. J Cell Sci 2000; 113 (Pt 3): 383-90.
80. Attisano L, Labbe E,. TGFbeta and Wnt pathway cross-talk. Cancer Metastasis Rev 2004; 23: 53-61.
81. Korkaya H, Paulson A, Charafe-Jauffret E, et al. Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling. PLoS Biol 2009; 7: e1000121.
82. Lim E, Vaillant F, Wu D, et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 2009; 15: 907-13.
83. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature 2000; 406: 747-52.
84. Bertucci F, Finetti P, Rougemont J, et al. Gene expression profiling identifies molecular subtypes of inflammatory breast cancer. Cancer Res 2005; 65: 2170-8.
85. Lohr M, Schmidt C, Ringel J, et al. Transforming growth factor-beta1 induces desmoplasia in an experimental model of human pancreatic carcinoma. Cancer Res 2001; 61: 550-5.
86. Kalluri R, Zeisberg M,. Fibroblasts in cancer. Nat Rev Cancer 2006; 6: 392-401.
87. Gaggioli C, Hooper S, Hidalgo-Carcedo C, et al. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol 2007; 9: 1392-400.
88. De Wever O, Mareel M,. Role of tissue stroma in cancer cell invasion. J Pathol 2003; 200: 429-47.
89. Hostettler L, Zlobec I, Terracciano L, et al. ABCG5-positivity in tumor buds is an indicator of poor prognosis in node-negative colorectal cancer patients. World J Gastroenterol 2010; 16: 732-9.
90. Zou H, Harrington JJ, Shire AM, et al. Highly methylated genes in colorectal neoplasia: implications for screening. Cancer Epidemiol Biomarkers Prev 2007; 16: 2686-96.
91. Wada H, Enomoto T, Fujita M, et al. Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors. Cancer Res 1997; 57: 5379-85.
92. Sreenan JJ, Hart WR,. Carcinosarcomas of the female genital tract. A pathologic study of 29 metastatic tumors: further evidence for the dominant role of the epithelial component and the conversion theory of histogenesis. Am J Surg Pathol 1995; 19: 666-74.
93. Fujii H, Yoshida M, Gong ZX, et al. Frequent genetic heterogeneity in the clonal evolution of gynecological carcinosarcoma and its influence on phenotypic diversity. Cancer Res 2000; 60: 114-20.
94. de Jong RA, Nijman HW, Wijbrandi TF, et al. Molecular markers and clinical behavior of uterine carcinosarcomas: focus on the epithelial tumor component. Mod Pathol 2011; 24: 1368-79.
95. Dacic S, Finkelstein SD, Sasatomi E, et al. Molecular pathogenesis of pulmonary carcinosarcoma as determined by microdissection-based allelotyping. Am J Surg Pathol 2002; 26: 510-6.
96. Shuch B, Said J, LaRochelle JC, et al. Histologic evaluation of metastases in renal cell carcinoma with sarcomatoid transformation and its implications for systemic therapy. Cancer 2010; 116: 616-24.
97. Moul JW, McCarthy WF, Fernandez EB, et al. Percentage of embryonal carcinoma and of vascular invasion predicts pathological stage in clinical stage I nonseminomatous testicular cancer. Cancer Res 1994; 54: 362-4.
98. Ulbright TM,. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Mod Pathol 2005; 18 Suppl 2: S61-79.
99. Norris HJ, Zirkin HJ, Benson WL,. Immature (malignant) teratoma of the ovary: a clinical and pathologic study of 58 cases. Cancer 1976; 37: 2359-72.
100. Masters JR, Koberle B,. Curing metastatic cancer: lessons from testicular germ-cell tumours. Nat Rev Cancer 2003; 3: 517-25.
101. International Germ Cell Cancer Collaborative Group. International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 1997; 15: 594-603.